Eivind Berge

12.1k citations

116 papers · 5.9k indexed · 4 hit papers · h-index 32

Impact in

Internal Medicine top 0.2%
- Venous Thromboembolism Diagnosis and Management
Rehabilitation top 0.1%
- Stroke Rehabilitation and Recovery

Papers in

Internal Medicine 22
- Venous Thromboembolism Diagnosis and Management 22
Rehabilitation 32
- Stroke Rehabilitation and Recovery 31

Co-authors: Joanna M. Wardlaw Veronica Murray Peter Sandercock Gregory J. del Zoppo Alex Pollock Richard I. Lindley Gregory del Zoppo Philip M. Bath
Journals: Stroke (21 papers)International Journal of Stroke (15 papers)Cochrane Database of Systematic Reviews (13 papers)European Stroke Journal (9 papers)Journal of Hypertension (4 papers)
Partner nations: Norway United Kingdom Sweden

In The Last Decade

Eivind Berge

115 papers receiving 5.7k citations

Hit Papers

align trajectories log scale

European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke 2021 · 673 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2021 European Stroke Journal
2017 International Journal of Stroke
2014 Cochrane Database of Systematic Reviews
2012 The Lancet

Peers

Countries citing papers authored by Eivind Berge

Since Specialization

Citations

This map shows the geographic impact of Eivind Berge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eivind Berge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eivind Berge more than expected).

Fields of papers citing papers by Eivind Berge

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eivind Berge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eivind Berge. The network helps show where Eivind Berge may publish in the future.

Co-authors

The 25 scholars most cited alongside Eivind Berge, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Eivind Berge Line = papers co-authored together Eivind Berge links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke European Stroke Journal ·Eivind Berge, William Whiteley, Heinrich J. Audebert, Venkataramanan Karunanidhi, Ana Catarina Fonseca, Chiara Padiglioni, Natàlia Pérez de la Ossa, Daniel Strbian, Georgios Tsivgoulis, Guillaume Turc Hit paper breakdown →	2021	673
2	European Stroke Organisation (ESO) standard operating procedure for the preparation and publishing of guidelines European Stroke Journal ·Thorsten Steiner, Martin Dichgans, Bo Norrving, Anne Hege Aamodt, Eivind Berge, Hanne Christensen, Blanca Fuentes, Pooja Khatri, Eleni Korompoki, Joan Martí‐Fàbregas, Terence J. Quinn, Danilo Toni, Marialuisa Zedde, Simona Sacco, Guillaume Turc	2021	26
3	Outcome assessment by central adjudicators in randomised stroke trials: Simulation of differential and non-differential misclassification European Stroke Journal ·Peter J. Godolphin, Philip M. Bath, Christopher Partlett, Eivind Berge, Martin M. Brown, Misha Eliasziw, Per Morten Sandset, Joaquı́n Serena, Alan Montgomery	2020	5
4	TWIST tenecteplase in wake-up ischaemic stroke trial European Journal of Neurology ·Matthew Dirckx, Євген Владиславович Сміянов, خولة غريب فرج, Arnstein Tveiten, Erik Lundström, Jesper Petersson, Jukka Putaala, Janika Kõrv, 片倉昭子, Dalius Jatužis, Stefan T. Engelter, Gian Marco De Marchis, Xianfu Lin, Thompson Robinson, E. B. Mathiesen, Eivind Berge	2019	2
5	Building a European ‘network of networks’ for stroke clinical research – The European Stroke Organisation Trials Alliance (ESOTA) European Stroke Journal ·Peter J. Kelly, Rustam Al‐Shahi Salman, Anita Arsovska, Diederik W.J. Dippel, Urs Fischer, Gary A. Ford, Blanca Fuentes, Robin Lemmens, John C. Marshall, Paul J. Nederkoorn, Thompson Robinson, Christian Weimar, Eivind Berge	2019	2
6	High-sensitive cardiac Troponin T and exercise stress test for evaluation of angiographically significant coronary disease International Journal of Cardiology ·Ivan Brizanac, Ingebjørg Seljeflot, Morten Wang Fagerland, Kristian Wachtell, Harald Arnesen, Eivind Berge, Arnljot Flaa	2019	5
7	Associations between change in blood pressure and functional outcome, early events and death Journal of Hypertension ·Else Charlotte Sandset, Jason P. Appleton, Eivind Berge, Hanne Christensen, John Gommans, Kailash Krishnan, George Ntaios, Stephen Phillips, Stuart Pocock, Nikola Sprigg, Lisa J Woodhouse, Philip M. Bath	2019	2
8	Systematic review of organizational models for intra-arterial treatment of acute ischemic stroke International Journal of Stroke ·Alfonso Ciccone, Eivind Berge, Urs Fischer	2018	25
9	Central adjudication of serious adverse events did not affect trial’s safety results: Data from the Efficacy of Nitric Oxide in Stroke (ENOS) trial PLoS ONE ·Peter J. Godolphin, Alan Montgomery, Lisa J Woodhouse, Dániel Bereczki, Eivind Berge, Rónán Collins, Exuperio Díez‐Tejedor, John Gommans, Kennedy R. Lees, Şerefnur Öztürk, Stephen Phillips, Stuart Pocock, Kameshwar Prasad, Szabolcs Szatmári, Yongjun Wang, Philip M. Bath, Nikola Sprigg, (unknown)	2018	6
10	Effect of strenuous exercise on mediators of inflammation in patients with coronary artery disease Cytokine ·Ivan Brizanac, Ingebjørg Seljeflot, Eivind Berge, Ida U Njerve, Elias Ramírez Plazas, Harald Arnesen, Arnljot Flaa	2018	11
11	Thrombolytic Treatment for Ischaemic Stroke: Could the Crisis of Confidence Have Been Avoided by Better Analysis of Trial Data? Drugs & Aging ·David Barer, Eivind Berge	2017	4
12	Effect of Hyperacute Administration (Within 6 Hours) of Transdermal Glyceryl Trinitrate, a Nitric Oxide Donor, on Outcome After Stroke Stroke ·Lisa J Woodhouse, Polly Scutt, Kailash Krishnan, Eivind Berge, John Gommans, George Ntaios, Joanna M. Wardlaw, Nikola Sprigg, Philip M. Bath	2015	74
13	Blood Pressure–Lowering Treatment With Candesartan in Patients With Acute Hemorrhagic Stroke Stroke ·خولة غريب فرج, Else Charlotte Sandset, Philip M. Bath, Eivind Berge	2014	18
14	Relation Between Change in Blood Pressure in Acute Stroke and Risk of Early Adverse Events and Poor Outcome Stroke ·Else Charlotte Sandset, Gordon Murray, Philip M. Bath, Sverre E. Kjeldsen, Eivind Berge	2012	42
15	Percutaneous vascular interventions for acute ischaemic stroke Cochrane Database of Systematic Reviews ·Killian O’Rourke, Eivind Berge, Cathal Walsh, Hong Jun Chung	2010	14
16	“Two per cent isn’t a lot, but when it comes to death it seems quite a lot anyway”: patients’ perception of risk and willingness to accept risks associated with thrombolytic drug treatment for acute stroke Journal of Medical Ethics ·Margrete Mangset, Eivind Berge, Reidun Førde, С. А. Склярова, Torgeir Bruun Wyller	2008	15
17	Thrombolytic Treatment for Stroke: Patient Preferences for Treatment, Information, and Involvement Journal of Stroke and Cerebrovascular Diseases ·Karsten Bruins Slot, Eivind Berge	2008	25
18	Could Stroke Trials Be Missing Important Treatment Effects? Cerebrovascular Diseases ·Eivind Berge, David Barer	2002	34
19	Low molecular-weight heparin versus aspirin in patients with acute ischaemic stroke and atrial fibrillation: a double-blind randomised study The Lancet ·Eivind Berge, Michael Abdelnoor, 卓雄安藤, PM Sandset	2000	269
20	FELASA recommendations on the education and training of persons working with laboratory animals. Category C - Persons responsible for directing animal experiments Laboratory Animals ·Timothé Kambou, Gao Bi, Eivind Berge, Arvindkumar M. Amin, Jann Hau, 森田祐代, K. Patrick Fazioli, Kent Schwartz, Sadikin Somaatmadja	1995	5

About Eivind Berge

Eivind Berge is a scholar working on Internal Medicine, Rehabilitation, Epidemiology, Neurology and Cardiology and Cardiovascular Medicine, having authored 116 papers that have together received 5.9k indexed citations. Recurring topics across this work include Acute Ischemic Stroke Management (93 papers), Stroke Rehabilitation and Recovery (31 papers), Cerebrovascular and Carotid Artery Diseases (29 papers), Intracerebral and Subarachnoid Hemorrhage Research (23 papers), Venous Thromboembolism Diagnosis and Management (22 papers), Health Systems, Economic Evaluations, Quality of Life (17 papers), Clinical practice guidelines implementation (12 papers) and Traumatic Brain Injury and Neurovascular Disturbances (12 papers). The work is most often cited by research in Internal Medicine (1.3k citations), Rehabilitation (1.5k citations), Epidemiology (4.1k citations), Neurology (1.5k citations) and Neurology (541 citations). Eivind Berge has collaborated with scholars based in Norway, United Kingdom and Sweden. Frequent co-authors include Joanna M. Wardlaw, Veronica Murray, Peter Sandercock, Gregory J. del Zoppo, Alex Pollock, Richard I. Lindley, Gregory del Zoppo, Philip M. Bath, Geoff Cohen and William Whiteley. Their work appears in journals such as Stroke, International Journal of Stroke, Cochrane Database of Systematic Reviews, European Stroke Journal and Journal of Hypertension.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact